MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Price, Forecast & Analysis
Europe - EPA:ALMKT - FR0010609263 - Common Stock
ALMKT.PA Key Statistics, Chart & Performance
The current stock price of ALMKT.PA is 0.0876 EUR. In the past month the price decreased by -8.75%. In the past year, price decreased by -56.16%.
ALMKT.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.33 | 105.58B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 22.81 | 48.88B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 18.38 | 49.34B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.87B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.91 | 23.45B | ||
| BIM.PA | BIOMERIEUX | 27.75 | 12.68B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.81 | 3.79B | ||
| DIA.MI | DIASORIN SPA | 16.9 | 3.28B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.71 | 1.30B | ||
| DRW8.DE | DRAEGERWERK AG | 9.49 | 1.15B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 27.98 | 1.05B | ||
| ELN.MI | EL.EN. SPA | 17.38 | 892.16M |
Related stock screener links
About ALMKT.PA
Company Profile
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 61 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
Company Info
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE FR
Employees: 65
Phone: 33148240345
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What does MAUNA KEA TECHNOLOGIES do?
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France and currently employs 61 full-time employees. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
What is the current price of ALMKT stock?
The current stock price of ALMKT.PA is 0.0876 EUR. The price decreased by -12.4% in the last trading session.
What is the dividend status of MAUNA KEA TECHNOLOGIES?
ALMKT.PA does not pay a dividend.
What is the ChartMill technical and fundamental rating of ALMKT stock?
ALMKT.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for ALMKT stock?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.16).
Is MAUNA KEA TECHNOLOGIES (ALMKT.PA) expected to grow?
The Revenue of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is expected to grow by 32.89% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ALMKT.PA Technical Analysis
ALMKT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA. ALMKT.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALMKT.PA Financial Highlights
Over the last trailing twelve months ALMKT.PA reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -114.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMKT.PA Forecast & Estimates
9 analysts have analysed ALMKT.PA and the average price target is 0.61 EUR. This implies a price increase of 598.63% is expected in the next year compared to the current price of 0.0876.
For the next year, analysts expect an EPS growth of 90% and a revenue growth 32.89% for ALMKT.PA